Introduction: the objective of this study was to describe the epidemiological, clinical, therapeutic and evolutionary aspects of priapism in children with sickle cell disease. Methodology: this was a descriptive retrospective study, lasting 6 years from January 1,2017 to December 31, 2022, carried out at the pediatric surgery unit of the Ignace Deen national hospital and at the SOS center drepa of morykanteyah. Itcovered 28 records of sickle cell patients aged 0 to 15 years. Results: we recorded 28 cases of priapism out of 1050 sickle cell patients, a frequency of 2.66%. The average age of patients was 9.79 years with the extremes of 5 and 14 years, 54% of cases were homogygous, pain and rigidity of the penis were the most frequent clinical signs, i e 100%. The duration of symptom evolution was greater than 36 hours in 53.57%. It was an acute priapism in 54% with a nocturnal occurrence in 57%. 39.29% had suffered 1 to 2 episodes of priapism in their history. The medical treatment involved analgesics, rehydration and oral etilefrine in 85.71%, 32.14% and 21.43% respectively. Intracavernous injection of etilefrine was the most used method with 35.71% success rate, while bilateral incision of the corpora cavernosa (distal Al-Ghorab shunt) was the ultimate remedy with 100% success rate. hit. Detumescence was obtained the same day in 60.71%. Fibrosis of the corpora cavernosa and relapse were the complications found. Conclusion: priapism in children with sickle cell disease is a relatively frequent urological emergency, early consultation and adequate care could reduce complications.
| Published in | Journal of Surgery (Volume 11, Issue 4) |
| DOI | 10.11648/j.js.20231104.11 |
| Page(s) | 77-80 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
Priapism, Sickle Cell Disease, Child
| [1] | Kassogué A, Coulibaly M, Ouattara Z, Diarra A, Tembely A, Jamal El Fassi MJ et al. Aspects clinique et thérapeutique du priapisme au CHU Gabriel Touré: étude de 36 cas. Pan Afr Med J. 2014; 17: 286. DOI: 10.11604/pamj.2014.17.286.4109. |
| [2] | Hsin-Hsiao Scott Wang, Katherine W. Herbst, Jennifer A. Rothman, Nirmish R. Shah, John S. Wiener, Jonathan C. Routh. Tendances du prérapisme lié à la drépanocytose dans les hôpitaux pour enfants des États-Unis. Ur. PedVolume 89, mars 2016, pages 118-122. Doi.org/10.1016/j.urology.2015.11.023. |
| [3] | Gbadoe A. D., Pitche P., Boronbossou S. - Profil clinique du priapisme intermittent chroniquedrépanocy t a i re. A propos de 12 cas. Sem. Hop. 2000. |
| [4] | A. D. Gbadoe, A. Akakpo-Vidah, P. Pitche, J. K. Assimadi. Priapisme drepanocytaire: Prise en charge par injections intracaverneuses d’etilefrine. Med. Trop. 2000 60 53–56. |
| [5] | LE Jesus, S. Dekermacher Priapisme chez l'enfant: revue de la physiopathologie et du traitement. J Pediatr (Rio J), 85 (2009), pp. 194–200 Google Scholar. |
| [6] | James F. Donaldson, Rowland W. Rees, Henrik A. Steinbrecher. Le priapisme chez les enfants: un examen complet et une ligne directrice clinique. J UrolPéd. Volume 10, Numéro 1, Février 2014, Pages 11-24. doi.org/10.1016/j.jpurol.2013.07.024. |
| [7] | TJ Bivalacqua, B. Musicki, O. Kutlu, AL Burnett. Nouveaux aperçus de la physiopathologie du priapisme associé à la drépanocytose. J Sex Med, 9 (2012), pp. 79–87. |
| [8] | JF Donaldson, RW Rees, HA Steinbrecher. Priapisme chez les enfants: un examen complet et une ligne directrice clinique. J PediatrUrol, 10 (2014), pp. 11–24. |
| [9] | E. Mantadakis, JD Cavender, ZR Rogers, DH Ewalt, GR Buchanan. Prévalence du priapisme chez les enfants et les adolescents atteints d'anémie falciforme. J PediatrHematolOncol, 21 (1999), p. 518–522. |
| [10] | Adeyoju AB, Olujohungbe ABK, Morris J, et al. Priapism in sicklecell disease; incidence, risk factor and complications. An international multicentre study. BJU Int 2002; 90: 898–902. |
| [11] | A. R. Okoko, A. S. W. Odzébé, E. Moyen, G. EkouyaBowassa, A. P. G. Oko, A. Mbika-Cardorelle et al. Priapisme chez l’enfant et l’adolescentdrépanocytaire homozygote à Brazzaville. Progrès en urologie (2014) 24, 57–61. Doi.org/10.1016/j.purol.2013.04.021. |
| [12] | Gbadoe AD, Dogba A, Segbena AY, Nyadanu DY. Priapismin sickle cell anemia in Togo, prevalence and knowledge of thiscomplication. Hemoglobin 2001; 25: 355–61. |
| [13] | Gbadoe AD, Diagne I, Ilboudo A. Priapisme chez le drépa-nocytaire Sénégalais: prévalence, attitudes et connaissances. Bull Soc PatholExot 2007; 100 (3): 179–81. |
| [14] | Pryor J, Akkus E, Alter G, Jordan G, Lebret T, Levine L, 1. et al. Priapism. J. Sex. Med. 2004; 1 (1): 116–20. |
| [15] | Bloom DA, WanJ, KeyD. Disorders of themale external genitalia and inguinal canal. In: Kelalis PP, King LR, Belman AB, editors. Clinical pediatric urology. 3e éd. Philadelphia: W. B. Saunders company; 1992. p. 1015–49. |
| [16] | Latoundji S, Ahlonsou G. M, Anani L, Zohoun L. Priapisme drépanocytaire au Benin. Med Afr Noire 1992; 39 (2): 122-126. |
| [17] | Roupret M, Beley S, Traxer O, et al (2005) Prise en charge du priapisme chez les patients drépanocytaires. Prog Urol 15 (3): 392–6; Spycher MA, Hauri D (1986) The ultrastructure of the erectile tissue in priapism. J Urol 135 (1): 142–7. |
| [18] | Falandry L (1999) Priapisme: traitement et résultats. À propos d’une série personnelle de 56 cas. Prog Urol 9 (3): 496–501. |
| [19] | Dekou A, Ouegnin G A, Konan P G, Kouame B, Manzan K. Les étiologies et facteurs de risque du priapisme à partir d’une série colligée dans le service d’urologie du CHU de Cocody à Abidjan. Rev Int SC Med 2006; 8 (3): 27-30. |
| [20] | Falandry L, Berlizot P, Fournier R, Mechali P, Thuret R, Palascak R, Houlgatte A. Traitement chirurgical du priapisme: expérience de 56 cas en milieu africain. Rev Med trop 2000; 60: 170-74. |
| [21] | Bouya PA, Lomina D (2005) Prise en charge du priapisme: à propos de 32 cas. Med Afr Noire 52: 453–6. |
| [22] | Roupret M, Beley S, Traxer O, Kirsch-Noir F, Jouannet P, Jardin A. Prise en charge du priapisme chez les patients drépanocytaires. Progrès en Urologie (2005), 15, 392–397. |
| [23] | Bouya P A, lomina D. Prise en charge du priapisme. A propos de 32 cas. In: Méd d’Afr Noire. 2005; 5209: 453-456. |
| [24] | Kane R. Niang L. Berthe H. Ndiaye A. Diao B. Ndoye A. et al. Prise en charge du priapisme à Dakar. Andrologie (2012) 22: 36–41. DOI 10.1007/s12610-012-0162-z. |
| [25] | A. Ben Chekroun, A. Lachkar, A. Soumana, M. H. Farih. Le priapisme de l’adulte. A propos de 16 casAnnUrol, 32 (1998), pp. 103–106 View Record in ScopusGoogleScholar. |
APA Style
Keita Doubany Mariame, Guirassy Mariama II, Keita Seydou, Diakité Moussa, Touré Balla Moussa, et al. (2023). Priapism in Children with Sickle Cell Disease: Description of a Series 28 Cases at CHU Conakry. Journal of Surgery, 11(4), 77-80. https://doi.org/10.11648/j.js.20231104.11
ACS Style
Keita Doubany Mariame; Guirassy Mariama II; Keita Seydou; Diakité Moussa; Touré Balla Moussa, et al. Priapism in Children with Sickle Cell Disease: Description of a Series 28 Cases at CHU Conakry. J. Surg. 2023, 11(4), 77-80. doi: 10.11648/j.js.20231104.11
AMA Style
Keita Doubany Mariame, Guirassy Mariama II, Keita Seydou, Diakité Moussa, Touré Balla Moussa, et al. Priapism in Children with Sickle Cell Disease: Description of a Series 28 Cases at CHU Conakry. J Surg. 2023;11(4):77-80. doi: 10.11648/j.js.20231104.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.js.20231104.11,
author = {Keita Doubany Mariame and Guirassy Mariama II and Keita Seydou and Diakité Moussa and Touré Balla Moussa and Fofana Naby and Camara Mama Aissata and Fofana Houssein and Touré Aboubacar},
title = {Priapism in Children with Sickle Cell Disease: Description of a Series 28 Cases at CHU Conakry},
journal = {Journal of Surgery},
volume = {11},
number = {4},
pages = {77-80},
doi = {10.11648/j.js.20231104.11},
url = {https://doi.org/10.11648/j.js.20231104.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.js.20231104.11},
abstract = {Introduction: the objective of this study was to describe the epidemiological, clinical, therapeutic and evolutionary aspects of priapism in children with sickle cell disease. Methodology: this was a descriptive retrospective study, lasting 6 years from January 1,2017 to December 31, 2022, carried out at the pediatric surgery unit of the Ignace Deen national hospital and at the SOS center drepa of morykanteyah. Itcovered 28 records of sickle cell patients aged 0 to 15 years. Results: we recorded 28 cases of priapism out of 1050 sickle cell patients, a frequency of 2.66%. The average age of patients was 9.79 years with the extremes of 5 and 14 years, 54% of cases were homogygous, pain and rigidity of the penis were the most frequent clinical signs, i e 100%. The duration of symptom evolution was greater than 36 hours in 53.57%. It was an acute priapism in 54% with a nocturnal occurrence in 57%. 39.29% had suffered 1 to 2 episodes of priapism in their history. The medical treatment involved analgesics, rehydration and oral etilefrine in 85.71%, 32.14% and 21.43% respectively. Intracavernous injection of etilefrine was the most used method with 35.71% success rate, while bilateral incision of the corpora cavernosa (distal Al-Ghorab shunt) was the ultimate remedy with 100% success rate. hit. Detumescence was obtained the same day in 60.71%. Fibrosis of the corpora cavernosa and relapse were the complications found. Conclusion: priapism in children with sickle cell disease is a relatively frequent urological emergency, early consultation and adequate care could reduce complications.},
year = {2023}
}
TY - JOUR T1 - Priapism in Children with Sickle Cell Disease: Description of a Series 28 Cases at CHU Conakry AU - Keita Doubany Mariame AU - Guirassy Mariama II AU - Keita Seydou AU - Diakité Moussa AU - Touré Balla Moussa AU - Fofana Naby AU - Camara Mama Aissata AU - Fofana Houssein AU - Touré Aboubacar Y1 - 2023/07/11 PY - 2023 N1 - https://doi.org/10.11648/j.js.20231104.11 DO - 10.11648/j.js.20231104.11 T2 - Journal of Surgery JF - Journal of Surgery JO - Journal of Surgery SP - 77 EP - 80 PB - Science Publishing Group SN - 2330-0930 UR - https://doi.org/10.11648/j.js.20231104.11 AB - Introduction: the objective of this study was to describe the epidemiological, clinical, therapeutic and evolutionary aspects of priapism in children with sickle cell disease. Methodology: this was a descriptive retrospective study, lasting 6 years from January 1,2017 to December 31, 2022, carried out at the pediatric surgery unit of the Ignace Deen national hospital and at the SOS center drepa of morykanteyah. Itcovered 28 records of sickle cell patients aged 0 to 15 years. Results: we recorded 28 cases of priapism out of 1050 sickle cell patients, a frequency of 2.66%. The average age of patients was 9.79 years with the extremes of 5 and 14 years, 54% of cases were homogygous, pain and rigidity of the penis were the most frequent clinical signs, i e 100%. The duration of symptom evolution was greater than 36 hours in 53.57%. It was an acute priapism in 54% with a nocturnal occurrence in 57%. 39.29% had suffered 1 to 2 episodes of priapism in their history. The medical treatment involved analgesics, rehydration and oral etilefrine in 85.71%, 32.14% and 21.43% respectively. Intracavernous injection of etilefrine was the most used method with 35.71% success rate, while bilateral incision of the corpora cavernosa (distal Al-Ghorab shunt) was the ultimate remedy with 100% success rate. hit. Detumescence was obtained the same day in 60.71%. Fibrosis of the corpora cavernosa and relapse were the complications found. Conclusion: priapism in children with sickle cell disease is a relatively frequent urological emergency, early consultation and adequate care could reduce complications. VL - 11 IS - 4 ER -
Information
Email: